Corticorelin ovine triflutate

Corticorelin ovine triflutate is a man-made form of a hormone that occurs naturally in the body.

Corticorelin ovine triflutate is used as part of a medical test in people with Cushing's syndrome. Cushing syndrome is caused by high levels of cortisol (a steroid hormone produced by the adrenal gland).

Corticorelin ovine triflutate is also used to help your doctor determine why your body is producing too much of its own cortisol.

Corticorelin ovine triflutate may also be used for purposes not listed in this medication guide.

Before you receive this medicine, tell your doctor about all your medical conditions and allergies.

Before you receive this medicine, tell your doctor about all your medical conditions and allergies.

FDA pregnancy category C. It is not known whether corticorelin ovine triflutate will harm an unborn baby. Tell your doctor if you are pregnant.

It is not known whether corticorelin ovine triflutate passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

Corticorelin ovine triflutate is injected into a vein through an IV. A healthcare provider will give you this injection in a hospital or clinic setting.

Corticorelin ovine triflutate is usually given as a single injection for a corticorelin test. Your caregivers will need to draw at least 5 blood samples from you before and after you receive the medicine.

In most cases, the blood is tested 15 minutes before and then right before you receive the injection. These tests will give your doctor two "baseline" measurements.

After you receive corticorelin ovine triflutate, your blood will be drawn again at 15 minutes, 30 minutes, and 60 minutes after the injection. This will help your doctor determine more about your condition.

The timing of your blood tests before and after the injection is important in assuring the most accurate results from a corticorelin test. Plan to stay in the care of your healthcare providers for at least 1 hour after your injection.

Since this medicine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

Symptoms of overdose include severe facial flushing, cardiovascular changes, and dyspnea. In the event of toxic overdose ( see ADVERSE REACTIONS ), adverse effects should be treated symptomatically.